Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Tengion, Inc.

TNGNQPNK
Healthcare
Biotechnology
$0.00
$-0.00(-0.00%)
U.S. Market opens in 12h 36m

Tengion, Inc. Fundamental Analysis

Tengion, Inc. (TNGNQ) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of 0.00%, and ROE of 1.88%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position5344779.88%
PEG Ratio-0.00

Areas of Concern

ROE1.88%
Operating Margin0.00%
We analyze TNGNQ's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 70.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
70.2/100

We analyze TNGNQ's fundamental strength across five key dimensions:

Efficiency Score

Weak

TNGNQ struggles to generate sufficient returns from assets.

ROA > 10%
-1.03%

Valuation Score

Excellent

TNGNQ trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

TNGNQ faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

TNGNQ maintains a strong and stable balance sheet.

Debt/Equity < 1
-1.60
Current Ratio > 1
1.31

Profitability Score

Weak

TNGNQ struggles to sustain strong margins.

ROE > 15%
188.30%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is TNGNQ Expensive or Cheap?

P/E Ratio

TNGNQ trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, TNGNQ's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Tengion, Inc. at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at 0.49 times EBITDA. This is generally considered low.

0.49

How Well Does TNGNQ Make Money?

Net Profit Margin

For every $100 in sales, Tengion, Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $1.88 in profit for every $100 of shareholder equity.

1.88%

ROA

Tengion, Inc. generates $-1.03 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.03%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-4.29 in free cash annually.

$-4.29

FCF Yield

TNGNQ converts -4287.95% of its market value into free cash.

-4287.95%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.60

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.31

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.88

vs 25 benchmark

ROA

Return on assets percentage

-1.03

vs 25 benchmark

ROCE

Return on capital employed

-1.83

vs 25 benchmark

How TNGNQ Stacks Against Its Sector Peers

MetricTNGNQ ValueSector AveragePerformance
P/E Ratio-0.0029.45 Better (Cheaper)
ROE188.30%779.00% Weak
Net Margin0.00%-24936.00% (disorted) Weak
Debt/Equity-1.600.26 Strong (Low Leverage)
Current Ratio1.314.65 Neutral
ROA-103.21%-19344.00% (disorted) Weak

TNGNQ outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Tengion, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ